(Last updated : 2025-02-20 14:00:57)
|
■ Journal
1.
|
|
Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastases 2023/08
|
|
■ Academic background
|
■ External Researcher ID
orcID |
https://orcid.org/0000-0003-3184-1999
|
|